Definium Therapeutics DFTX
NASDAQ DFTX
$38.41 +2.24 (+6.19%)
At close: Sep 28, 2026 · 4:00 PM EDT

Definium Therapeutics (DFTX) Other Non-Current Assets (2022 - 2026)

Updated

Definium Therapeutics (DFTX) reported Other Non-Current Assets of $880,000 for Q2 2026, down 25.0% from $1.17 million a year earlier but up 8.4% from the prior quarter.

Analysis

Definium Therapeutics (DFTX) Other Non-Current Assets (2022 - 2026) Analysis & Trends

At the end of FY2025, Definium Therapeutics posted Other Non-Current Assets of $862,000, up 40.6% from FY2024.

  • Other Non-Current Assets has a three-year compound annual growth rate of 37.6% (FY2022 to FY2025).
  • By year, Other Non-Current Assets came in at $613,000 in FY2024 (+173.7%), $224,000 in FY2023 (-32.3%) and $331,000 in FY2022.
  • Five-year quarterly Other Non-Current Assets spans a low of $144,000 in Q1 2024 and a high of $1.17 million in Q2 2025.
  • Year over year, Other Non-Current Assets gained in seven of the last eight quarters, with growth averaging 114.1%.
  • The high point for year-over-year Other Non-Current Assets in five years was Q1 2025 (growth of 320.8%); the low point was Q1 2024 (a decline of 52.0%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $812,000 (Q1 2026), $862,000 (Q4 2025) and $1.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 14.27 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 10.73 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 4.75 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 1.25 Bn
10 Definium Therapeutics 4.00 Bn 4.00 Bn - 880,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 880,000.00
Mar 31, 2026 812,000.00
Dec 31, 2025 862,000.00
Sep 30, 2025 1.15 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 606,000.00
Dec 31, 2024 613,000.00
Sep 30, 2024 493,000.00
Jun 30, 2024 534,000.00
Mar 31, 2024 144,000.00
Dec 31, 2023 224,000.00
Sep 30, 2023 229,000.00
Jun 30, 2023 268,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 331,000.00
API Access

Definium Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=DFTX&period=max&api_key=YOUR_API_KEY